"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." IF YOU’VE NEVER had a prostate cancer screening, you may worry that it will be embarrassing and ...
Dr. Ali Kasraeian from Kasraeian Urology is the first in our area to utilize a new minimally invasive treatment, called Focal Therapy, that precisely targets and destroys prostate cancer tumors.
The average age of men who get diagnosed is 67.
Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.
When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery ...
AI is changing how cancer care decisions are made, empowering patients and doctors to make more personalized choices. For ...
A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...
Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," meaning they do not attract enough immune cells to mount a strong attack.
GRAND RAPIDS, Mich. (WOOD) — Like many patients, a diagnosis for prostate cancer came out of nowhere for Grand Rapids resident Larry Vaughn. “It was scary at the time,” Vaughn said. “No symptoms. I ...